via gaycitynews.com, by Perry N. Halkitis, Ph.D., M.S “But is this radical shift from the behavioral to the biomedical the right course of action for all of us?   For me there are two bigger issues — one which I will fully address here, and the other to which I will allude.” Despite our best attempts over Read More >>

  Heads up IRMA, you have little more than a week to submit abstracts and apply for scholarships for the Microbicides 2012 conference scheduled for April 15 – 18, 2012 in Sydney, Australia. Please take special note of the time – as Nov 17 in Australia could very well be Nov 16 where you are. Here is Read More >>

via NIH News Media Branch Dr. Francis S. Collins, M.D., Ph.D, director of the National Institutes of Health, announced the release of the Biennial Report of the Director, NIH, for fiscal years 2008 and 2009. The report provides an integrated portrait of NIH research activities, making it easy for Congress, advocates and patient groups and the general Read More >>

Via AVACThe report tracks the public, philanthropic and commercial investment in biomedical HIV prevention in 2009 including preventive and therapeutic HIV vaccines, microbicides, oral pre-exposure prophylaxis (PrEP), adult male circumcision, prevention of mother to child transmission, and HSV-2 suppression and prevention. The report finds stability in funding for HIV prevention research from 2008 to 2009. HIV vaccines Read More >>

AVAC‘s 13th annual report, Turning the Page surveys, critiques and proposes recommendations for the field of biomedical prevention research: AIDS vaccines, microbicides and ARV-based prevention strategies such as PrEP and treatment as prevention. As the report describes, scientific developments in several arenas of biomedical prevention research have re-energized the search for additional strategies. In the vaccine field Read More >>